An Open-Label, Phase I/II Trial of ABI-007 (A Cremophor EL-Free, Protein Stabilized, Nanoparticle, Paclitaxel) Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 27 Mar 2013
At a glance
- Drugs Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 23 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00073723).
- 16 Aug 2005 New trial record.